RxDoctor Payments Data

Therese Keeling

Psychiatry · New Albany, INNPI 1104985605

Payments from drug & device makers

$3,777in general payments, 2019–2025

Across 294 payments — averaging $12.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Supernus Pharmaceuticals, Inc.$504
  • Otsuka America Pharmaceutical, Inc.$282
  • Takeda Pharmaceuticals U.S.A., Inc.$199
  • Lundbeck LLC$197
  • Ironshore Pharmaceuticals Inc.$136
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,74799%
  • Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,777 in reported general payments places this provider in the 80th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyvanseLisdexamfetamine Dimesylate23$10,312
Vilazodone Hcl53$4,779
Aripiprazole43$4,703
Lisdexamfetamine Dimesylate17$3,666
Lurasidone Hcl36$3,660
Desvenlafaxine Succinate ErDesvenlafaxine Succinate40$3,537
Dextroamphetamine Sulfate19$2,282
Bupropion XlBupropion Hcl66$1,273
Alprazolam56$950
Gabapentin51$796
Methylphenidate Hcl19$717
Fluvoxamine Maleate13$641
Duloxetine Hcl12$598
Trazodone Hcl44$431
Fluoxetine Hcl56$408

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$199$10,31223 claims
Almatica Pharma LLCSertraline Hcl$40$15124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in New Albany

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →